The American Academy Of Pain Medicine

The physicians' voice in pain medicine
  • Foundation
  • Store
  • Career Center
  • Press
  • Join-Renew
Search: Go
Member Login: Login

Enter the AAPM
Members' Community

  • Member Center
  • Patient Center
  • Library
  • Advocacy
  • Practice Management
  • CME
  • Annual Meeting
  • Safe Prescribing Resources
  • PI-CME Portal

Library

Home > Library > For Pain Researchers > 2012 Poster Abstracts
  • Research in the News
  • For Pain Researchers
    • 2013 Poster Abstracts
    • 2012 Poster Abstracts
    • Research Resources
    • Research Presentations
    • Search Clinical Trials (NIH)
    • Register a Clinical Trial (NIH)
    • Medline - US National Library of Medicine
  • Clinical Guidelines and Resources
  • Pain Facts
  • Archives
  • FDA Updates, Recalls and Warnings
  • Presented at the 2012 AAPM Annual Meeting « Back

    145

    Painful Foot Drop Secondary to Herpes Zoster Infection

    Kevin Kohan, DO, kevinkohan@gmail.com1, Hector Delucca, MD2, (1) University of Cincinnati, Cincinnati, Ohio, (2) Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, New York

    View Poster

    Setting: Teaching Hospital. Case: A 68-year-old male with a history of diabetes mellitus presented to the emergency room with severe 5-day history of progressively worsening of left lower extremity pain accompanied by a vesicular rash. The pain was described by the patient as 10/10 with a sharp and shooting quality localized on the dorsum of the foot. On physical examination the patient had a vesicular rash with a clear exudate over the dorsum of the left foot (Figure 1). Patient developed progressive weakness of left ankle dorsiflexors with strength of 0/5 on the 11th day of admission. Patient had decreased sensation to pinprick and light touch on the dorsum of the left foot and DTR were unobtainable. Results: Cultures of the exudate were positive for Zoster (VZV) and all imagining tests were negative. Although he received a 1-week course of Valacyclovir 1000mg every 8 hours, his pain persisted. This pain was treated initially with Lyrica 50mg q12, Fentanyl patch 25mcg q72 hours, Cymbalta 60mg, and Lidocaine 1% topical patches. The pain was debilitating him and he underwent left peroneal nerve block with sensorcaine and obtained complete relief from 10/10 to 0/10 for a total of 3 days, with gradual return of pain symptoms by day 7. Patient subsequently underwent a sciatic nerve block and on 1-month follow-up his pain had subsided to a 4/10. Conclusion: A multidimension treatment modality is necessary to treat patients with recalcitrant herpes zoster.

    Funding: None

  • Home
  • Member Center
  • Patient Center
  • Library
  • Advocacy
  • Practice Management
  • CME
  • Annual Meeting
  • Contact Us
  • Members' Community
  • Privacy Policy
  • Sitemap
Close

Members Only Alert Message

Please login to access AAPM member only information.
Forgot your login information?

Sign Up Today!

Join AAPM today and be part of the primary organization for physicians practicing in the specialty of pain medicine and begin accessing AAPM member benefits. 

Join
Or

Log In

Please log in and you will be redirected to the requested page.

Log In